Preclinical and first-in-human evaluation of PRX-105, a PEGylated, plant-derived, recombinant human acetylcholinesterase-R

被引:13
作者
Atsmon, Jacob [1 ,4 ]
Brill-Almon, Einat [2 ]
Nadri-Shay, Carmit [2 ]
Chertkoff, Raul [2 ]
Alon, Sari [2 ]
Shaikevich, Dimitri [1 ,4 ]
Volokhov, Inna [1 ,4 ]
Haim, Kirsten Y. [1 ,4 ]
Bartfeld, Daniel [2 ]
Shulman, Avidor [2 ]
Ruderfer, Ilya [2 ]
Ben-Moshe, Tehila [2 ]
Shilovitzky, Orit [2 ]
Soreq, Hermona [3 ]
Shaaltiel, Yoseph [2 ]
机构
[1] Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Clin Res Ctr, IL-69978 Tel Aviv, Israel
[2] Protalix Biotherapeut, IL-20100 Carmiel, Israel
[3] Hebrew Univ Jerusalem, Dept Biol Chem, Inst Life Sci, IL-91905 Jerusalem, Israel
[4] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel
关键词
AChE-R; Prophylaxis; Organophosphorous; Preclinical; First-in-human; HUMAN SERUM BUTYRYLCHOLINESTERASE; NERVE AGENT TOXICITY; CATALYTIC SCAVENGERS; PROTECTION; BIOSCAVENGERS; PROPHYLAXIS; SOMAN; RISK; CARBOXYLESTERASE; QUATERNARY;
D O I
10.1016/j.taap.2015.06.004
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
PRX-105 is a plant-derived recombinant version of the human 'read-through' acetylcholinesterase splice variant (AChE-R). Its active site structure is similar to that of the synaptic variant, and it displays the same affinity towards organophosphorus (OP) compounds. As such, PRX-105 may serve as a bio-scavenger for OP pesticides and chemical warfare agents. To assess its potential use in prophylaxis and treatment of OP poisoning we conducted several preliminary tests, reported in this paper. Intravenous (IV) PRX-105 was administered to mice either before or after exposure to an OP toxin. All mice who received an IV dose of 50 nmol/kg PRX-105, 2 min before being exposed to 1.33 x LD50 and 1.5 x LD50 of toxin and 10 min after exposure to 1.5 x LD50 survived. The pharmacokinetic and toxicity profiles of PRX-105 were evaluated in mice and mini-pigs. Following single and multiple IV doses (50 to 200 mg/kg) no deaths occurred and no significant laboratory and histopathological changes were observed. The overall elimination half-life (t(1/2)) in mice was 994 (+/- 173) min. Additionally, a first-in-human study, to assess the safety, tolerability and pharmacokinetics of the compound, was conducted in healthy volunteers. The t(1/2) in humans was substantially longer than in mice (average 26.7 h). Despite the small number of animals and human subjects who were assessed, the fact that PRX-105 exerts a protective and therapeutic effect following exposure to lethal doses of OP, its favorable safety profile and its relatively long half-life, renders it a promising candidate for treatment and prophylaxis against OP poisoning and warrants further investigation. (C) 2015 Elsevier Inc. All rights reserved.
引用
收藏
页码:202 / 209
页数:8
相关论文
共 41 条
[1]   BUTYRYLCHOLINESTERASE AND ACETYLCHOLINESTERASE PROPHYLAXIS AGAINST SOMAN POISONING IN MICE [J].
ASHANI, Y ;
SHAPIRA, S ;
LEVY, D ;
WOLFE, AD ;
DOCTOR, BP ;
RAVEH, L .
BIOCHEMICAL PHARMACOLOGY, 1991, 41 (01) :37-41
[2]   Suitability of human butyrylcholinesterase as therapeutic marker and pseudo catalytic scavenger in organophosphate poisoning: A kinetic analysis [J].
Aurbek, N. ;
Thiermann, H. ;
Eyer, F. ;
Eyer, P. ;
Worek, F. .
TOXICOLOGY, 2009, 259 (03) :133-139
[3]  
Ballough G.P.H., 2008, MED ASPECTS CHEM WAR, P221
[4]   Acetylcholinesterase/paraoxonase interactions increase the risk of insecticide-induced Parkinson's disease. [J].
Benmoyal-Segal, L ;
Vander, T ;
Shifman, S ;
Bryk, B ;
Ebstein, R ;
Marcus, EL ;
Stessman, J ;
Darvasi, A ;
Herishanu, Y ;
Friedman, A ;
Soreq, H .
FASEB JOURNAL, 2005, 19 (01) :452-+
[5]   Adaptive Alternative Splicing Correlates with Less Environmental Risk of Parkinsonism [J].
BenMoyal-Segal, Liat ;
Soreq, Lilach ;
Ben-Shaul, Yoram ;
Ben-Ari, Shani ;
Ben-Moshe, Tehila ;
Aviel, Sigal ;
Bergman, Hagai ;
Soreq, Hermona .
NEURODEGENERATIVE DISEASES, 2012, 9 (02) :87-98
[6]   The acute treatment of nerve agent exposure [J].
Cannard, Kevin .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2006, 249 (01) :86-94
[7]   Organophosphate-induced brain damage: Mechanisms, neuropsychiatric and neurological consequences, and potential therapeutic strategies [J].
Chen, Yun .
NEUROTOXICOLOGY, 2012, 33 (03) :391-400
[8]   Comparison of polyethylene glycol-conjugated recombinant human acetylcholinesterase and serum human butyrylcholinesterase as bioscavengers of organophosphate compounds [J].
Cohen, Ofer ;
Kronman, Chanoch ;
Raveh, Lily ;
Mazor, Ohad ;
Ordentlich, Arie ;
Shafferman, Avigdor .
MOLECULAR PHARMACOLOGY, 2006, 70 (03) :1121-1131
[9]   Bioscavengers for the protection of humans against organophosphate toxicity [J].
Doctor, BP ;
Saxena, A .
CHEMICO-BIOLOGICAL INTERACTIONS, 2005, 157 :167-171
[10]   Management of acute organophosphorus pesticide poisoning [J].
Eddleston, Michael ;
Buckley, Nick A. ;
Eyer, Peter ;
Dawson, Andrew H. .
LANCET, 2008, 371 (9612) :597-607